ArticleJournal of medical cases2025

Long Durable Response With Trastuzumab Deruxtecan Monotherapy in a Triple-Negative Metastatic Breast Cancer Patient With Human Epidermal Growth Factor Receptor 2 Mutation: A Long-Term Follow-Up and Literature Review.

Muralidhar Idamakanti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.